Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

815 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale.
Montejo AL, Deakin JF, Gaillard R, Harmer C, Meyniel F, Jabourian A, Gabriel C, Gruget C, Klinge C, MacFayden C, Milligan H, Mullings E, Goodwin G. Montejo AL, et al. Among authors: goodwin g. J Psychopharmacol. 2015 Oct;29(10):1119-28. doi: 10.1177/0269881115599385. Epub 2015 Aug 12. J Psychopharmacol. 2015. PMID: 26268533 Clinical Trial.
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial.
Browning M, Bilderbeck AC, Dias R, Dourish CT, Kingslake J, Deckert J, Goodwin GM, Gorwood P, Guo B, Harmer CJ, Morriss R, Reif A, Ruhe HG, van Schaik A, Simon J, Sola VP, Veltman DJ, Elices M, Lever AG, Menke A, Scanferla E, Stäblein M, Dawson GR. Browning M, et al. Among authors: goodwin gm. Neuropsychopharmacology. 2021 Jun;46(7):1307-1314. doi: 10.1038/s41386-021-00981-z. Epub 2021 Feb 26. Neuropsychopharmacology. 2021. PMID: 33637837 Free PMC article. Clinical Trial.
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.
BALANCE investigators and collaborators; Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E. BALANCE investigators and collaborators, et al. Lancet. 2010 Jan 30;375(9712):385-95. doi: 10.1016/S0140-6736(09)61828-6. Epub 2010 Jan 19. Lancet. 2010. PMID: 20092882 Clinical Trial.
815 results